vs
Side-by-side financial comparison of HYDROFARM HOLDINGS GROUP, INC. (HYFM) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
HYDROFARM HOLDINGS GROUP, INC. is the larger business by last-quarter revenue ($25.1M vs $18.3M, roughly 1.4× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -963.9%, a 960.9% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -32.7%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-4.3M). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -31.9%).
Hydrofarm Inc. (HYFM) is an American company specializing in the distribution and manufacture of controlled environment agriculture equipment and supplies.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
HYFM vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.1M | $18.3M |
| Net Profit | $-242.2M | $-554.0K |
| Gross Margin | 8.5% | 21.1% |
| Operating Margin | -953.8% | -2.2% |
| Net Margin | -963.9% | -3.0% |
| Revenue YoY | -32.7% | -25.6% |
| Net Profit YoY | -1282.7% | 26.7% |
| EPS (diluted) | $-52.09 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.1M | $18.3M | ||
| Q3 25 | $29.4M | $15.9M | ||
| Q2 25 | $39.2M | $16.1M | ||
| Q1 25 | $40.5M | $18.9M | ||
| Q4 24 | $37.3M | $24.7M | ||
| Q3 24 | $44.0M | $28.3M | ||
| Q2 24 | $54.8M | $25.8M | ||
| Q1 24 | $54.2M | $22.7M |
| Q4 25 | $-242.2M | $-554.0K | ||
| Q3 25 | $-16.4M | $-1.8M | ||
| Q2 25 | $-16.9M | $-1.5M | ||
| Q1 25 | $-14.4M | $-1.5M | ||
| Q4 24 | $-17.5M | $-756.0K | ||
| Q3 24 | $-13.1M | $1.7M | ||
| Q2 24 | $-23.4M | $343.0K | ||
| Q1 24 | $-12.6M | $-1.7M |
| Q4 25 | 8.5% | 21.1% | ||
| Q3 25 | 11.6% | 14.3% | ||
| Q2 25 | 7.1% | 15.6% | ||
| Q1 25 | 17.0% | 16.1% | ||
| Q4 24 | 4.9% | 14.7% | ||
| Q3 24 | 19.4% | 22.0% | ||
| Q2 24 | 19.8% | 17.6% | ||
| Q1 24 | 20.2% | 13.5% |
| Q4 25 | -953.8% | -2.2% | ||
| Q3 25 | -44.1% | -9.9% | ||
| Q2 25 | -34.0% | -8.4% | ||
| Q1 25 | -27.1% | -7.2% | ||
| Q4 24 | -40.5% | -2.1% | ||
| Q3 24 | -20.5% | 6.8% | ||
| Q2 24 | -35.3% | 2.0% | ||
| Q1 24 | -16.1% | -5.8% |
| Q4 25 | -963.9% | -3.0% | ||
| Q3 25 | -55.8% | -11.0% | ||
| Q2 25 | -43.0% | -9.3% | ||
| Q1 25 | -35.5% | -8.0% | ||
| Q4 24 | -46.9% | -3.1% | ||
| Q3 24 | -29.9% | 5.9% | ||
| Q2 24 | -42.8% | 1.3% | ||
| Q1 24 | -23.3% | -7.6% |
| Q4 25 | $-52.09 | $-0.01 | ||
| Q3 25 | $-3.51 | $-0.05 | ||
| Q2 25 | $-3.63 | $-0.05 | ||
| Q1 25 | $-3.12 | $-0.04 | ||
| Q4 24 | $-3.80 | $-0.02 | ||
| Q3 24 | $-2.86 | $0.04 | ||
| Q2 24 | $-5.10 | $0.01 | ||
| Q1 24 | $-2.75 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.3M | $10.7M |
| Total DebtLower is stronger | $50.0K | — |
| Stockholders' EquityBook value | $-63.3M | $37.0M |
| Total Assets | $123.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.3M | $10.7M | ||
| Q3 25 | $10.7M | $13.6M | ||
| Q2 25 | $11.0M | $12.5M | ||
| Q1 25 | $13.7M | $11.4M | ||
| Q4 24 | $26.1M | $15.7M | ||
| Q3 24 | $24.4M | $12.3M | ||
| Q2 24 | $30.3M | $11.9M | ||
| Q1 24 | $24.2M | $6.6M |
| Q4 25 | $50.0K | — | ||
| Q3 25 | $111.7M | — | ||
| Q2 25 | $111.6M | — | ||
| Q1 25 | $110.0M | — | ||
| Q4 24 | $114.7M | — | ||
| Q3 24 | $114.8M | — | ||
| Q2 24 | $114.9M | — | ||
| Q1 24 | $115.4M | — |
| Q4 25 | $-63.3M | $37.0M | ||
| Q3 25 | $178.3M | $37.0M | ||
| Q2 25 | $195.0M | $30.4M | ||
| Q1 25 | $209.9M | $31.5M | ||
| Q4 24 | $223.7M | $32.6M | ||
| Q3 24 | $243.0M | $29.1M | ||
| Q2 24 | $255.0M | $23.5M | ||
| Q1 24 | $278.0M | $20.6M |
| Q4 25 | $123.8M | $57.1M | ||
| Q3 25 | $369.7M | $57.5M | ||
| Q2 25 | $389.9M | $52.6M | ||
| Q1 25 | $410.6M | $54.0M | ||
| Q4 24 | $426.1M | $59.2M | ||
| Q3 24 | $445.9M | $57.1M | ||
| Q2 24 | $463.4M | $53.0M | ||
| Q1 24 | $494.0M | $50.7M |
| Q4 25 | — | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.0M | $2.3M |
| Free Cash FlowOCF − Capex | $-4.3M | $2.2M |
| FCF MarginFCF / Revenue | -17.1% | 12.0% |
| Capex IntensityCapex / Revenue | 1.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.1M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.0M | $2.3M | ||
| Q3 25 | $-37.0K | $-1.3M | ||
| Q2 25 | $1.7M | $1.8M | ||
| Q1 25 | $-11.8M | $-3.5M | ||
| Q4 24 | $2.7M | $865.0K | ||
| Q3 24 | $-4.5M | $4.3M | ||
| Q2 24 | $3.8M | $1.4M | ||
| Q1 24 | $-2.3M | $-2.4M |
| Q4 25 | $-4.3M | $2.2M | ||
| Q3 25 | $-207.0K | $-1.5M | ||
| Q2 25 | $1.4M | $1.7M | ||
| Q1 25 | $-12.0M | $-3.5M | ||
| Q4 24 | $2.4M | $470.0K | ||
| Q3 24 | $-5.3M | $4.1M | ||
| Q2 24 | $3.4M | $1.2M | ||
| Q1 24 | $-3.7M | $-2.5M |
| Q4 25 | -17.1% | 12.0% | ||
| Q3 25 | -0.7% | -9.6% | ||
| Q2 25 | 3.7% | 10.5% | ||
| Q1 25 | -29.6% | -18.8% | ||
| Q4 24 | 6.4% | 1.9% | ||
| Q3 24 | -12.0% | 14.4% | ||
| Q2 24 | 6.2% | 4.5% | ||
| Q1 24 | -6.9% | -11.1% |
| Q4 25 | 1.3% | 0.5% | ||
| Q3 25 | 0.6% | 1.4% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.6% | 0.3% | ||
| Q4 24 | 0.7% | 1.6% | ||
| Q3 24 | 1.8% | 0.7% | ||
| Q2 24 | 0.7% | 1.1% | ||
| Q1 24 | 2.7% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HYFM
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
